Nuchev Pty Ltd (AU:NUC) has released an update.
Nuchev Pty Ltd has reported significant growth following the acquisition of bWellness, with proforma FY24 Group revenue doubling to $21.2m and sales of Oli6 Nutritionals up by 45% to $10.9m. The company has successfully launched new high-margin products in China, contributing to a 5% increase in overall sales margins. Alongside this, Nuchev continues to strengthen its position in the Australian Retail Goat Infant Formula market and maintains a robust cash position with disciplined operational cost management.
For further insights into AU:NUC stock, check out TipRanks’ Stock Analysis page.
